
News|Articles|April 1, 2002
New ACC/AHA guidelines reshape drug therapy for acute coronary syndromes
Prompted by a flurry of new evidence, two leading cardiology groups have revised their guidelines for the management of acute coronary syndromes just 18 months after the last revision.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Payer Implications and Final Takeaways from the BE BOLD Trial
2
A conversation with Tiffany Phung, Pharm.D., CSP, about how patient outcomes drive specialty pharmacy strategy
3
The biosimilars market is projected to nearly double — here's where the growth is coming from
4
Endometriosis increases the risk of Type 2 diabetes
5






















